id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0241-0004,FDA,FDA-2004-D-0241,Gu8idance,Supporting & Related Material,GDL-Guidance,2005-10-20T04:00:00Z,2005,10,,,2020-04-28T17:33:54Z,,0,0,0900006480471997
FDA-2004-D-0241-0005,FDA,FDA-2004-D-0241,Gu8idance,Supporting & Related Material,GDL-Guidance,2005-10-20T04:00:00Z,2005,10,,,2020-04-28T17:34:30Z,,0,0,0900006480471998
FDA-2004-D-0241-0006,FDA,FDA-2004-D-0241,FDA,Notice,NAD-Notice of Availability of Data,2005-10-20T04:00:00Z,2005,10,2005-10-19T04:00:00Z,,2008-04-12T00:35:20Z,,0,0,0900006480471999
FDA-2004-D-0241-0003,FDA,FDA-2004-D-0241,FDA,Notice,NEC-Notice of Extension,2005-01-06T05:00:00Z,2005,1,2005-01-05T05:00:00Z,2005-02-19T04:59:59Z,2008-04-12T00:35:20Z,,0,0,0900006480471987